A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
复制标题
DOI:
10.1183/09031936.00154009
复制
发表时间:
2010-11-01
影响因子:
24.3
通讯作者:
Nakano, T.
中科院分区:
文献类型:
--
作者:
Tabata, C.;Hirayama, N.;Nakano, T.
Malignant pleural mesothelioma (MPM) is an aggressive malignant tumour associated with asbestos exposure that has only a limited response to conventional therapy; therefore, diagnosing MPM early is very important. We have previously reported that angiopoietin (Ang)-1 was correlated with bleomycin-induced pulmonary fibrosis.Here, we investigated the association of Ang-1 with the development of MPM cells, which originate from mesenchymal cells similar to lung fibroblasts, and demonstrated that Ang-1 stimulated the growth and migration of MPM cells in vitro. We also demonstrated that patients with MPM had significantly higher serum levels of Ang-1 in comparison to a population who had been exposed to asbestos but had not developed MPM. The patients with advanced-stage MPM showed higher levels of Ang-1 than the early-stage MPM patients and the Kaplan-Meier method revealed a significant correlation between serum Ang-1 levels and survival.We propose the possibility that Ang-1 plays an important role in MPM tumour growth and our data suggest that the serum concentration of Ang-1 could be useful as prognostic factor.